Key result
Chemotherapy for primary cardiac lymphoma ends in fatal low-output syndrome in a 69-year-old man.
Why the study?
Primary cardiac lymphoma is very rare and generally regarded to have a poor prognosis.
Comparison
Chemotherapy with cyclophosphamide, hydroxydaunomycin, oncovin, and prednisone
Design
Case report
Follow-up
18 days
Authors
Loading...
Highlights fatal chemotherapy complications in primary cardiac lymphoma; leaves open optimal timing and regimens for prospective evaluation.
Case Report (n=1)
Primary cardiac lymphoma is a rare condition with a poor prognosis, highlighting the potential need for early diagnosis to improve outcomes.
Saotome et al. (2002) conducted a case report in Primary cardiac lymphoma (n=1). Chemotherapy (cyclophosphamide, hydroxydaunomycin, oncovin, and prednisone) was evaluated. A 69-year-old man with primary cardiac lymphoma died on the 18th day of chemotherapy due to low-output syndrome and multiple organ failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: